 |
인쇄하기
취소
|
Yuhan's new peptic ulcer drug soon on phase III studies.
Yuhan announced that the phase III clinical studies of YH1885 (Revanex: revaprazan) was scheduled to conduct for the duodenal ulcer in Oct. and for the GERD (gastro-esophageal reflux disease) in the end of this year or the early of next year.
The phase II study for the duodenal ulcer was performed from Apr. to Dec. 2001 and for the GERD and other gastric disorders was still underway, all res...
The phase II study for the duodenal ulcer was performed from Apr. to Dec. 2001 and for the GERD and other gastric disorders was still underway, all res...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.